Full Press Release Details
Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, March 13, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Pacira BioSciences, Inc. (“Pacira” or the “Company”) (NASDAQ: PCRX) investors of a class action representing investors that bought securities between August 2, 2023 and August 8, 2024, inclusive (the "Class Period"). Pacira investors have until March 14, 2025 to file a lead plaintiff motion.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
According to the complaint, on August 9, 2024, Pacira issued a press release announcing the outcome of its patent infringement lawsuit against eVenus. The company disclosed that the court had ruled its U.S. Patent No. 11,033,495 (the “‘495 patent”) invalid, thereby confirming that eVenus was not infringing on any rights.
The ‘495 patent covers Exparel, Pacira’s primary revenue driver, accounting for approximately 80% of the company’s total revenue. Analysts have expressed concerns that this ruling could undermine the validity of Pacira’s other patents, potentially paving the way for increased generic competition and higher litigation costs.
Following this announcement, Pacira’s stock price plummeted. After closing at $22.36 per share on August 8, 2024, the stock fell to a low of $11.70 per share on August 9, 2024, marking a single-day decline of over 47%.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
Attorney Advertising